Clinical Trial Update: Treatment of Secondary Hyperparathyroidism in the Uremic Patient [NA]

View source ↗

Summary

A clinical trial (NCT00469599) examining treatment of secondary hyperparathyroidism in uremic patients with chronic kidney disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism
• Vitamin Deficiency

Snippet

Sponsor: Zealand University Hospital | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | NA | Status: TERMINATED